Take 2 Indomethacin (Suppositories) and Call Me in the Morning? The Role of Nonsteroidal Anti-inflammatory Drugs in Protection Against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.

[1]  B. Lacy,et al.  Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients. , 2016, Gastroenterology.

[2]  Vikesh K. Singh,et al.  Evaluation of Pharmacologic Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Systematic Review. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  M. Freeman,et al.  Pancreatic stent placement remains a cornerstone of prevention of post-ERCP pancreatitis, but it requires specialized techniques. , 2015, Gastrointestinal endoscopy.

[4]  B. Han,et al.  Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. , 2014, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[5]  M. Freeman,et al.  Editorial: Pharmacologic Prophylaxis Alone Is Not Adequate to Prevent Post-ERCP Pancreatitis , 2014, The American Journal of Gastroenterology.

[6]  D. Drossman,et al.  Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. , 2014, JAMA.

[7]  V. Wadhwa,et al.  A Meta-Analysis on the Role of Rectal Diclofenac and Indomethacin in the Prevention of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis , 2014, Pancreas.

[8]  H. Yuhara,et al.  Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis , 2014, Journal of Gastroenterology.

[9]  M. Shiono,et al.  Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis , 2014, Journal of Gastroenterology.

[10]  A. Barkun,et al.  Meta‐analysis: rectal indomethacin for the prevention of post‐ERCP pancreatitis , 2013, Alimentary pharmacology & therapeutics.

[11]  P. Moayyedi,et al.  Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis , 2013, Endoscopy.

[12]  X. Zou,et al.  Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. , 2012, Gastrointestinal endoscopy.

[13]  Richard S. Kwon,et al.  A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. , 2012, The New England journal of medicine.

[14]  T. Noda,et al.  Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial , 2012, Journal of Gastroenterology.

[15]  Nitin Kumar,et al.  Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. , 2010, Gastrointestinal endoscopy.

[16]  N. Fujita,et al.  Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial , 2010, Journal of Gastroenterology.

[17]  A. Andriulli,et al.  European Society of Gastrointestinal Endoscopy (ESGE)Guideline: Prophylaxis of post-ERCP pancreatitis , 2010, Endoscopy.

[18]  Ji-Young Park,et al.  Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial. , 2009, Gastrointestinal endoscopy.

[19]  F. Liu,et al.  Risk Factors for ERCP-Related Complications: A Prospective Multicenter Study , 2009, The American Journal of Gastroenterology.

[20]  M. Khoshbaten,et al.  Role of diclofenac in reducing post‐endoscopic retrograde cholangiopancreatography pancreatitis , 2008, Journal of gastroenterology and hepatology.

[21]  P. Lankisch.  Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. , 2008, The American journal of gastroenterology.

[22]  A. Ojeda,et al.  Efecto de la administración de indometacina rectal sobre los niveles séricos de amilasa posteriores a colangiopancreatografía retrógrada endoscópica y su impacto en la aparición de episodios de pancreatitis secundaria , 2007 .

[23]  M. Sivak,et al.  Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. , 2007, Gastrointestinal endoscopy.

[24]  A. Ojeda,et al.  Effect of the rectal administration of indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography , and its impact on the development of secondary pancreatitis episodes , 2007 .

[25]  R. Carter,et al.  Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. , 2003, Gastroenterology.

[26]  C. Ng,et al.  European Society of Gastrointestinal and Abdominal Radiology (ESGAR) , 2002, European Radiology.

[27]  M. E. Ryan,et al.  Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. , 1997, Gastrointestinal endoscopy.